Odyssey Therapeutics, Inc.
ODTX
$19.21
$0.321.67%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 175.75M | 129.35M | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 9.35M | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | 185.10M | -- | |||
|
|
|||||
| Total Current Assets | 185.10M | -- | |||
| Net Property, Plant & Equipment | 24.48M | -- | |||
| Long-term Investments | 14.07M | -- | |||
| Goodwill | 14.07M | -- | |||
| Total Other Intangibles | 160.00K | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 5.26M | -- | |||
| Total Assets | 229.07M | -- | |||
|
|
|||||
| Total Accounts Payable | 8.22M | -- | |||
| Total Accrued Expenses | 6.77M | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 5.37M | -- | |||
| Total Finance Division Other Current Liabilities | 1.85M | -- | |||
| Total Other Current Liabilities | 1.85M | -- | |||
| Total Current Liabilities | 22.21M | -- | |||
|
|
|||||
| Total Current Liabilities | 22.21M | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | 20.75M | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | 6.24M | -- | |||
| Total Liabilities | 49.21M | -- | |||
|
|
|||||
| Common Stock & APIC | 82.85M | -- | |||
| Retained Earnings | -606.40M | -- | |||
| Treasury Stock & Other | -147.00K | -- | |||
| Total Common Equity | -523.69M | -382.53M | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | 703.56M | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | 703.56M | 514.94M | |||
|
|
|||||
| Total Common Equity | -523.69M | -382.53M | |||
| Total Preferred Equity | 703.56M | 514.94M | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 179.86M | 132.41M | |||
|
|
|||||